Studies thyroid nodules and thyroid cancer with imaging and samples
Studies people with thyroid nodules or thyroid cancer, using 68-Gallium Dotatate scans.
Plain-language title generated from the registry record
Registry title: Studies on Tumors of the Thyroid
Key facts
- Where
- Bethesda, United StatesSee the site
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Trial code
- NCT00001160
- Record updated
- 9 November 2026
- Original description
Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer.Read full original descriptionShow less
Studies on Thyroid Nodules and Thyroid Cancer
Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer.
The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies....
Exclusion: Serious underlying medical conditions that restrict diagnostic testing or therapy such as renal failure, congestive cardiac failure or active coexisting non-thyroid carcinoma requiring intervention before thyroid cancer is addressed; An individual who meets any of the following criteria will be excluded from participation in this study:.
INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:; Male or female, adults or children >= 6 months+; Patients with known or suspected thyroid nodules and/or thyroid cancer; At risk family members of patients who have a genetic susceptibility to developing thyroid cancer.